HMGCR and cardiovascular disorder: They act as 3-hydroxymethyl-3-methylglutaryl-coenzyme A lyase (HMG-CoA) reductase inhibitors, reduce cholesterol synthesis, and lower serum cholesterol levels, which significantly reduces the morbidity and mortality of cardiovascular diseases [176].